Supplementary Figure S7 from Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant

• DOI: 10.1158/2326-6066.24709710.v1
• Publication Date: 2023-12-01T07:23:01Z
• Authors: Bo Wang; Ziwei Ou; Wenlong Zhong; Lin Huang; Wenjian Liao; Yiyu Sheng; Zhixing Guo; Junyu Chen; Wenjuan Yang; Ke Chen; Xiaodong Huang; Tenghao Yang; Tianxin Lin; Jian Huang

<p>Combination (combo) of VISTA mAb 13F3 with sODN-dsRNA induced TME changes in MB49 tumors</p>